Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Liver Cancer|June 24, 2026
Disease Complexity and Nodule-Specific Responses to Atezolizumab plus Bevacizumab in Advanced Hepatocellular CarcinomaSae Yumita, Sadahisa Ogasawara, Makoto Fujiya, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|May 3, 2025
Evaluating two rechallenge strategies of immune checkpoint inhibitors: Durvalumab plus tremelimumab in advanced hepatocellular carcinomaTakuya Yonemoto, Sadahisa Ogasawara, Naoya Kanogawa, et al.
International Cancer Conference Journal|April 3, 2026
Exploratory case series of conversion to carbon ion radiotherapy after systemic therapy in advanced hepatocellular carcinomaHaruka Anzai, Chihiro Miwa, Sadahisa Ogasawara, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|June 29, 2024
Cytokine release syndrome following durvalumab and tremelimumab in advanced hepatocellular carcinoma: A case report with cytokine and damage-associated molecular pattern analysisTomomi Ozaki, Sae Yumita, Sadahisa Ogasawara, et al.
JHEP Reports : Innovation in Hepatology|December 9, 2025
The efficacy of atezolizumab plus bevacizumab for advanced hepatocellular carcinoma in relation to tumor-infiltrating lymphocytesHiroaki Kanzaki, Takamasa Ishino, Sadahisa Ogasawara, et al.
Pageof 1